tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Crinetics Pharmaceuticals (CRNX) Income Statement

Compare
500 Followers

Crinetics Pharmaceuticals Income Statement

Last quarter (Q4 2024), Crinetics Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Crinetics Pharmaceuticals's net income was $-80.59M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.04M$ 4.01M$ 4.74M$ 1.08M$ 71.00K
Gross Profit
$ 1.04M$ 4.01M$ 3.35M$ -184.00K$ -56.93M
Operating Expenses
$ 339.89M$ 226.62M$ 172.62M$ 108.78M$ 74.95M
Depreciation and Amortization
$ 0.00$ 1.10M$ 1.39M$ 1.26M$ 1.23M
EBITDA
$ -338.85M$ -221.51M$ -166.90M$ -106.78M$ -72.59M
Operating Income
$ -338.85M$ -222.61M$ -167.88M$ -107.70M$ -74.95M
Other Income/Expenses
$ 40.45M$ 8.08M$ 3.96M$ 61.00K$ 1.14M
Pretax Income
$ -298.41M$ -214.53M$ -163.92M$ -107.64M$ -73.81M
Net Income
$ -298.41M$ -214.53M$ -159.95M$ -106.72M$ -72.86M
Per Share Metrics
Basic EPS
$ -3.69$ -3.69$ -3.08$ -2.78$ -2.39
Diluted EPS
$ -3.69$ -3.69$ -3.08$ -2.78$ -2.39
Weighted Average Shares Outstanding
80.78M 58.07M 51.98M 38.44M 30.45M
Weighted Average Shares Outstanding (Diluted)
80.78M 58.07M 51.98M 38.44M 30.45M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis